novo nordisk a/s-b (NOVOB:Copenhagen)
Esper Boel Ph.D.
Head of Biotechnology and Vice-President, Novo Nordisk A/S
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
Dr. Esper Boel, Ph.D. serves as Corporate Vice President of Novo Nordisk A/S in Denmark and Head of the Biotechnology Unit, which is it's core facility in the disciplines of molecular biology, recombinant expression of therapeutic proteins in bacterial and mammalian cell systems, cell biology, bioprocess technology and antibody technology. Dr. Boel has worked with Novo Nordisk A/S for more than 25 years. Since 2001, Dr. Boel has been responsible for the establishment ...
Novo AlléPhone: 45 44 44 88 88
Bagsvaerd, Capital Region of Denmark 2880
Fax: 45 44 49 05 55
Board Members Memberships*
Bachelor's Degree 1979
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|George A. Scangos Ph.D.||Chief Executive Officer and Director|
Biogen Idec Inc.
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Rakesh Kapoor||Chief Executive Officer, Executive Director and Member of Nomination Committee|
Reckitt Benckiser Group plc
|Richard A. Gonzalez||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$1.5M||Compensation as of Fiscal Year 2013.|